(2S,3S)-2,3-Dihydroxysuccinic acid - 17-(cyclobutylmethyl)morphinan-3,14-diol (1:1)(CAS: 58786-99-5)

The compound (2S,3S)-2,3-Dihydroxysuccinic acid - 17-(cyclobutylmethyl)morphinan-3,14-diol (CAS: 58786-99-5) is subject to various regulatory guidelines, including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. It is important to follow specific labeling, storage, and disposal guidelines to ensure safety and compliance.

Alternatives to (2S,3S)-2,3-Dihydroxysuccinic acid - 17-(cyclobutylmethyl)morphinan-3,14-diol (CAS: 58786-99-5) include similar compounds such as isomers or analogs. Common alternatives in synthesis include using different starting materials or reagents, such as 2,3-dihydroxybutanedioic acid, which can serve as a precursor in the synthesis of similar compounds.

The market for (2S,3S)-2,3-Dihydroxysuccinic acid - 17-(cyclobutylmethyl)morphinan-3,14-diol (CAS: 58786-99-5) is growing due to its potential applications in pharmaceuticals. Research trends include exploring its use in pain management and other therapeutic areas. Market trends show increasing demand for novel compounds with specific pharmacological properties.

Waste containing (2S,3S)-2,3-Dihydroxysuccinic acid - 17-(cyclobutylmethyl)morphinan-3,14-diol (CAS: 58786-99-5) should be collected in a suitable container and stored away from direct sunlight and heat. It should be disposed of through professional waste management services, following local and international regulations for hazardous waste. Environmental protection precautions, such as minimizing exposure to air and water, are crucial during handling and disposal.